2BLAIS J, BEAUCHAMP D, CHAMBERLAND S. Azithromycin uptake and intracellular accumulation by Toxoplasma gondii-infected macrophages[J]. J Antimicrob Chemother, 1994,34: 371-382.
3DEGERLI K, KILIMCIOGLU AA, KURT O, et al. Efficacy of azithromycin in a murine toxoplasmosis model, employing a Tcoxoplasama gondii strain from Turkey[J]. Acta Trop, 2003,88:45-50.
4THEAUDIN M, BODAGHI B, CASSOUX N, et al. Extensive toxoplasmic retinochoroiditis: Diagnostic and therapeutic management[J]. J Fr Ophtalmol, 2003,26: 921-927.
5JACOBSON JM. HAFNER R. REMINGTON J, et al. Dose-escalation,phase Ⅰ/Ⅱ study azithromycin and pyrimethamine for thetreatment of toxoplasmic encephalitis in AIDS[J]. AIDS, 2001, 15: 583-589.
6LODE H. BORNER K, KOEPPE P, et al. Azithromycin-review of key chemical, pharmacokinetic and microbiological features[J]. J Antimicrob Chemother, 1996, 37(S): 1-8.
7BERG-CANDOLFI M, CANDOLFI E. Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamyc in inmurine Toxoplasma infection[J]. Int J Parasitol, 1996,26: 1321-1323.
